Time to 12-month remission and treatment failure for generalised and unclassified epilepsy (Q33658630)

28 July 2017

title

Time to 12-month remission and treatment failure for generalised and unclassified epilepsy (English)

1 reference

28 July 2017

Laura J Bonnett

1

0 references

Paula Williamson

series ordinal

4

object named as

Paula R Williamson

1 reference

28 July 2017

2

Catrin Tudur Smith

1 reference

28 July 2017

David Smith

3

1 reference

28 July 2017

David Chadwick

series ordinal

5

1 reference

28 July 2017

Anthony G Marson

series ordinal

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

29 November 2013

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 July 2017

published in

1 reference

28 July 2017

volume

85

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

603-610

1 reference

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

A twin study of genetic influences on epilepsy outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Remission of epilepsy: results from the National General Practice Study of Epilepsy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Centring in regression analyses: a strategy to prevent errors in statistical inference.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP-2013-306040

The multidrug transporter hypothesis of refractory epilepsy: corroboration and contradiction in equal measure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP-2013-306040

Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4033033

Randomised study of antiepileptic drug withdrawal in patients in remission. Medical Research Council Antiepileptic Drug Withdrawal Study Group

30 October 2018

1 reference

12 December 2020

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

1 reference

12 December 2020

The use of fractional polynomials to model continuous risk variables in epidemiology

1 reference

12 December 2020

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

12 December 2020

Factors predicting prognosis of epilepsy after presentation with seizures

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP-2013-306040

1 reference

28 July 2017

1 reference

28 July 2017

1 reference